This Solicitation opportunity from Department Of Defense was posted on May 6, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Top

NORETHINDRONE AND E

Closed

SPE2DP-26-T-3280Federal

Submission Closed05/12/2026, 05:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 325412

New

DIBBS

LEVOFLOXACIN TABLETThe contract pertains to the procurement of Levofloxacin tablets, identified by NSN/Part Number 6505-01-444-6632, with a purchase quantity of one unit under request number 7017178498. The solicitation, designated SPE2DP-26-T-3807, was issued by the Defense Logistics Agency on behalf of the Department of Defense with a posting date of June 15, 2026, and a response deadline set for June 22, 2026. This solicitation is categorized as a federal opportunity without specific set-aside conditions or NAICS code information provided. The contract will be performed within the United States, although exact location details are unspecified. The Defense Logistics Agency is managing the acquisition, and the solicitation details are accessible via a designated DIBBS URL for interested parties.

Defense Logistics Agency

POSTED

DEADLINE

Sole Source Total Parenteral Nutrition (TPN) solutions, including TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid same-day delivery, seven days a weekThis contract involves the sole source procurement of Total Parenteral Nutrition (TPN) solutions, specifically including products such as TrophAmine, Plenamine, Nutrilipid, and SMOF Lipid. The key requirement is for same-day delivery, seven days a week, ensuring continuous availability of these critical nutritional solutions. The solicitation number is HT941026N0069, with the notice posted on June 15, 2026, and a response deadline set for June 30, 2026. The contract falls under the NAICS code 325412, associated with pharmaceutical preparation manufacturing, and is issued by the Defense Health Agency located at Camp Pendleton, California. The place of performance is identified within Washington state, ZIP code 98431, indicating where the deliveries or contract services will be conducted. There is no set-aside designation for this procurement, reflecting an open competitive strategy or a direct sole-source justification. Primary and secondary points of contact are provided for further inquiries, with the primary contact being CHA-ON Gordon. The contract aims to support the Department of Defense’s ongoing medical and nutritional needs for personnel, emphasizing timely and reliable supply chain delivery for essential TPN products.

Defense Health Agency Hcd West

POSTED

DEADLINE

6505--Lab Supplies | Radiopharm | 5-Year Indefinite Delivery/Indefinite Quantity (IDIQ) | VA Pittsburgh Healthcare SystemThe contract solicits bids for the supply of laboratory materials related to radiopharmaceuticals under a five-year indefinite delivery, indefinite quantity (IDIQ) agreement for the VA Pittsburgh Healthcare System. The solicitation, identified by the number 36C24426Q0669, invites vendors to provide these specialized lab supplies consistent with NAICS code 325412, which pertains to pharmaceutical preparation manufacturing. The Department of Veterans Affairs, specifically the 244-NETWORK Contract Office 4 located in Pittsburgh, Pennsylvania, is managing this procurement. Vendors interested in participating must submit their proposals by July 10, 2026, with the solicitation having been posted on June 12, 2026. The contract aims to ensure a steady and flexible supply of radiopharmaceutical lab materials to support healthcare operations over a multi-year period, accommodating variable quantities as needed. The primary point of contact for this contract is Christa L. Stine, a contract specialist reachable via email, facilitating communication and clarifications throughout the solicitation process.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

Supply of PYP Cold VialsThe contract involves the supply of PYP cold vials to the VA Pittsburgh facility, requiring a stringent same-day delivery service within a 2-hour window during business hours. The supplier must ensure the maintenance of the cold chain throughout the delivery process, complying with all relevant regulatory standards to preserve the integrity of the product. This contract is categorized under NAICS code 325412 and is managed by the Department of Veterans Affairs, specifically through the 244-NETWORK Contract Office 4. Responses to this subcontract opportunity must be submitted by July 10, 2026. The contract emphasizes urgency and precision in delivery, reflecting the critical nature of the supplies for the facility's operations. The detailed logistics and regulatory compliance underscore the importance of reliability and quality control in fulfilling the contract requirements. Information about the contract was made available as of June 12, 2026.

244-NETWORK Contract Office 4 (36C244)

POSTED

DEADLINE

PETNET PharmaceuticalThe Medical Readiness Contracting Office-West plans to award a firm fixed-price sole source contract to PETNET Solutions INC., doing business as Siemens Healthineers, for the supply of FDA-approved radiopharmaceuticals including FDG, NaF, Amyvid, and Posluma. The contract encompasses a base period from October 1, 2026, to September 30, 2027, with an option period extending to September 30, 2028. This contract will be executed under statutory authority FAR 12.102(a), allowing for non-competitive procurement due to the determination that only one source is reasonably available to meet the government's specific needs. The contract falls under the NAICS code 325412 for Pharmaceutical Preparation Manufacturing with a size standard of 1,300 employees. The delivery location for the products will be the William Beaumont Army Medical Center at Fort Bliss, Texas. The notice explicitly states that no competitive proposals will be solicited, and the government will not honor any capability briefings or telephonic inquiries related to this contract. The point of contact for inquiries is Darryl O. Bryant, with a secondary contact being Karina Haddix, both representatives of the Department of Defense’s Medical Readiness Contracting Office-West.

W40M MRC0 West

POSTED

5 days ago

DEADLINE

in 6 days

AI Contract Overview

The contract involves the procurement of Norethindrone and Ethinyl Estradiol tablets, USP, specifically packaged in cycles of 28 tablets, with each package containing six cycles. The tablets are supplied in varying dosages of active ingredients per cycle and include inert tablets, with a total shelf life mandated at 36 months, ensuring that no less than 31 months remain from the manufacturing date to delivery. Packaging and labeling must strictly comply with Medical Marking Standard No. 1A dated February 4, 2013, to ensure proper identification and safe handling. Storage conditions are specified at 25°C with allowable temperature excursions between 15°C and 30°C. The packaging requirements emphasize commercial packing standards that protect the contents from damage during shipment, and exterior shipping containers must meet criteria to enable acceptance and safe delivery at the lowest carrier rate. The solicitation is issued by the Department of Defense's Medical Supply Chain Pharmacy FSA through the Defense Logistics Agency with a solicitation number SPE2DP-26-T-3280. Bidders and contracting officials are required to adhere to specific technical and quality requirements as outlined in the DLA master list, with reference to current revisions based on solicitation and award dates. Delivery is mandated within five days to the destination point, with inspection and acceptance also taking place at destination. The contract’s specific details include a quantity request of three packages (each package containing six cycles of 28 tablets), and compliance with the FDA’s regulatory oversight for this drug is mandatory. The main contractor identified is Teva Pharmaceuticals USA, Inc., and the solicitation deadline is May 12, 2026.

General Info

Procurement of Norethindrone-Ethinyl Estradiol tablets, six-cycle packs, 36-month shelf life, delivered within five days.

Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

NAICS

325412 - Pharmaceutical Preparation Manufacturing View NAICS

Place of Performance

UNIT 3865 BOX, APO, AE, 09126-3865, US

Set-Aside

NONE

Documents

(1)

SPE2DP-26-T-3280.pdf

PDF

AI Contract Breakdown

Uniform Contract Format

What is UCF?

Uniform Contract Format (UCF) uses AI to break down any contract into standardized sections—scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseClosed

PostedMay 6

Solicitation

Response DeadlineMay 12

Deadline has passed

Submission Closed

05/12/2026, 05:00:00 PM UTC

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

AgencyDepartment Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Contacts1 person available

OfficeUS

Organization / Agency

Department Of Defense → MEDICAL SUPPLY CHAIN PHARM FSA

Office AddressUS

Contacts

JAMES MARIANI

contact@example.gov

+1 (555) 000-0000

Full Description

NORETHINDRONE AND E
NORETHINDRONE AND ETHINYL ESTRADIOL TABLETS,USP
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
7 TABLETS WITH 0.5 MG & 35 MCG; 7 TABLETS WITH 0.75 MG & 35 MCG AND 7
TABLETS WITH 1 MG AND 25 MCG OF ACTIVE INGREDIENT PLUS 7 INERT TABLETS
28 TABLETS PER CYCLE, 6 CYCLES PER PKG UNIT OF ISSUE "PACKAGE" (6
CYCLES OF 28 TABLETS) SHALL HAVE A SHELF LIFE OF 36 MONTHS. NOT LESS
THAN 31 MONTHS SHALL HAVE ELAPSED FROM DATE OF MANUFACTURE TO DATE OF
DELIVERY TO THE GOVERNMENT.. LABELING AND MARKING MUST IN ACCORDANCE
WITH MEDICAL MARKING STANDARD NO. 1A DATED 4 FEBRUARY 2013. STORE AT
25°C (77°F); EXCURSIONS PERMITTED TO 15°#30°C (59°#86°F)
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO fssb@dla.mil. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
1 PG = 168 TT
1 PG = 168 TT
This device or drug is regulated by the FDA.
SPE2DP-26-T-3280
SECTION B
Note to Buyers: The contracting official shall send a referral in EBS to the product specialist for confirmation. Please include bidder name and bidder contact information, manufacturer name, manufacturer part number, and item description. RS020: Shelf-life requirement RS001 for a TYPE I (CODE Q) item with a shelf life of 36 months (non-extendable) applies to this item.
. SHALL BE MARKED IAW THE LATEST EDITION OF THE MEDICAL MARKING STANDARD NO. 1. MMS NO. 1 IS AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
TEVA PHARMACEUTICALS USA, INC. 3V8D7 P/N NDC00555-9012-58
DLA issues this document using the DoD authorized unit of issue, please refer to the following URL to determine the corresponding ANSI X12 unit of issue.
https://view.officeapps.live.com/op/view.aspx?src=https%3A%2F%2Fwww.dla.mil%2FPortals%2F104%2FDocuments% 2FDLMS%2FeApplications%2FLogDataAdmin%2FUnitofIssueandPurchaseUnit.xlsx&wdOrigin=BROWSELINK
CLIN PR PRLI UI QUANTITY UNIT PRICE TOTAL PRICE.
0001 7016658215 0001 PG 3.000
NSN/MATERIAL:6505015062659
DELIVERY (IN DAYS):0005
DELIVER FOB: DESTINATION
QTY VARIANCE: PLUS 0% MINUS 0%
INSPECTION POINT: DESTINATION
ACCEPTANCE POINT: DESTINATION
PREP FOR DELIVERY:
PKGING DATA MIL-STD-2073-1E
SPECIAL NSN/Part Number: 6505-01-506-2659 Quantity: 3 PG Purchase Request: 7015321235QTY: 3 Delivery: 5 days ADO